Immunotherapy drugs continue to gain momentum across a growing range of disease areas with blockbusters such as Merck’s ...

Biodesix has expanded its collaboration with Bio-Rad for the development and clinical validation of in vitro diagnostic (IVD) ...

Mode Sensors has gained US Food and Drug Administration (FDA) clearance for Re:Balans, a fluid monitoring wearable, setting ...

Ampa has raised $8.5m and initiated the US roll-out of its transcranial magnetic stimulation (TMS) system for treating major ...

Nyra Medical has commenced a trial to test its new Cardiac Leaflet Enhancer (CARLEN) system in individuals with FMR.

Boston Scientific has lifted its fiscal year 2025 (FY25) profit outlook to between $3.02 and $3.04 per share amid continued ...

Demand for gender-specific medical innovation means that medtech devices related to women’s health are drawing investor ...

Hologic is set for acquisition by Blackstone and TPG for up to $18.3bn in enterprise value, as part of a definitive agreement ...

Hyperfine has enrolled the first subjects in the PRISM PMR trial, which aims to assess the application of the Swoop portable ...

Adagio Medical has secured $19m upfront through a private placement, aimed at advancing its ULTC technology for VT treatment.

Germany-based roclub has raised $11.7m to fuel the US launch of its platform for the remote operation (teleoperation) of medical devices in healthcare settings where practitioner shortfalls exist.

Biocomposites has launched its SYNICEM range of spacers for hip, knee, and shoulder revision surgery in the US.